A Trial to Compare Treatment With Surlorian (ARM210, S48168) to Placebo in Effects on Muscle Strength and Safety in Adults With Autosomal Dominant RYR1-related Myopathy

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2026
This study is testing a medicine called surlorian in adults who have a genetic muscle condition known as autosomal dominant RYR1-related myopathy (RYR1-RM). The goal is to find out whether surlorian improves muscle weakness, and whether it is safe and well tolerated.
Epistemonikos ID: b38447e44631ceea1ac0465970fed469d9e9451f
First added on: May 01, 2026